Cart
sales@molnova.com
BRD5648
CAS No. 2056261-42-6
BRD5648( (R)-BRD0705 )
Catalog No. M26074 CAS No. 2056261-42-6
BRD5648 is an inactive (R)-enantiomer of BRD0705.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 219 | Get Quote |
|
| 10MG | 322 | Get Quote |
|
| 25MG | 538 | Get Quote |
|
| 50MG | 768 | Get Quote |
|
| 100MG | 1062 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBRD5648
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRD5648 is an inactive (R)-enantiomer of BRD0705.
-
DescriptionBRD5648 is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies.(In Vitro):BRD5648 does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
-
In VitroBRD5648, the inactive enantiomer of BRD0705, does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
-
In Vivo——
-
Synonyms(R)-BRD0705
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2056261-42-6
-
Formula Weight321.424
-
Molecular FormulaC20H23N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 300 mg/mL (933.36 mM)
-
SMILESCC[C@]1(C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sulfaphenazole
Sulfaphenazole is an inhibitor of CYP2C9 (Ki: 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki: 63/29 μM for CYP2C8/CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19).
-
MMBO
MMBO is a potent, highly selective, brain penetrant, orally active inhibitor of GSK-3 with IC50 of 37 and 53 nM for GSK-3α and GSK-3β, respectively.
-
Bikinin
Bikinin (Abrasin) is a plant GSK-3/Shaggy-like kinases inhibitor that activates brassinosteroid (BR) signaling downstream of the BR receptor.
